5+
installs · ≈9
—
0 ratings
2022-10-18
first release
2024-05-20
last update
Description
Application for participants in Bristol Myers Squibb CA116-003 study.
You are invited to participate in the Bristol Myers Squibb CA116-003 study. This app is specifically intended to capture MORAb-202 (farletuzumab etceteribulin) reactions and symptoms.
What's new
Bug fixes and performance improvements.
Details
| Version | 5.0.700.01-prod |
|---|---|
| Minimum Android version | 6.0 |
| Reviews | 0 |
| Available in | American Samoa, Australia, Belgium, Bulgaria, St. Barthélemy, Chile, Spain, France, French Guiana, Guadeloupe, Guam, St. Martin and 13 more |
| Developer contacts | on the Business plan |
| Collected | 2026-11-14 |
This data in the API
The full record in JSON costs 1 token.
curl -H "X-API-Key: YOUR_KEY" \ "https://apkapi.com/api/v1/app?id=com.medable.bms.ca116003"
